The role and regulation of complement activation as part of the thromboinflammation elicited in cell therapies

Molecular Immunology

Volumn 61, Issue 2, 2014, Pages 185-190

  Nilsson, Bo ^a   Teramura, Yuji ^a,b   Ekdahl, Kristina N ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF TOKYO   (Japan)

^c LINNAEUS UNIVERSITY   (Sweden)

Author keywords

Coagulation; Complement; Contact system; Instant blood mediated inflammatory reaction (IBMIR); Platelets; Thromboinflammation

Indexed keywords

ACETYLCYSTEINE; ACTIVATED PROTEIN C; BIOMATERIAL; BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; CNTO 859; COMPLEMENT; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; D DIMER; FIBRIN; FIBRINOGEN RECEPTOR ANTAGONIST; FICOLIN; MANNAN BINDING LECTIN; MELAGATRAN; MONOCLONAL ANTIBODY; THROMBIN; UNCLASSIFIED DRUG;

CELL THERAPY; COMPLEMENT ACTIVATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOSIS;

COAGULATION; COMPLEMENT; CONTACT SYSTEM; INSTANT BLOOD-MEDIATED INFLAMMATORY REACTION (IBMIR); PLATELETS; THROMBOINFLAMMATION;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HUMANS; INFLAMMATION; THROMBOSIS;

EID: 84907598129     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.06.009     Document Type: Review

References (52)

1. Akima S., Hawthorne W.J., Favaloro E., Patel A., Blyth K., Mudaliar Y., Chapman J.R., O'Connell P.J. Tirofiban and activated protein C synergistically inhibit the Instant Blood Mediated Inflammatory Reaction (IBMIR) from allogeneic islet cells exposure to human blood. Am. J. Transplant. 2009, 9:1533-1540. (official journal of the American Society of Transplantation and the American Society of Transplant Surgeons).
2. Amara U., Flierl M.A., Rittirsch D., Klos A., Chen H., Acker B., Bruckner U.B., Nilsson B., Gebhard F., Lambris J.D., Huber-Lang M. Molecular intercommunication between the complement and coagulation systems. J. Immunol. 2010, 185:5628-5636.
3. Back J., Lang M.H., Elgue G., Kalbitz M., Sanchez J., Ekdahl K.N., Nilsson B. Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces. Biomaterials 2009, 30:6573-6580.
4. Back J., Lood C., Bengtsson A.A., Ekdahl K.N., Nilsson B. Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus. Arthritis Res. Ther. 2013, 15:R206.
5. Back J., Sanchez J., Elgue G., Ekdahl K.N., Nilsson B. Activated human platelets induce factor XIIa-mediated contact activation. Biochem. Biophys. Res. Commun. 2010, 391:11-17.
6. Bennet W., Groth C.G., Larsson R., Nilsson B., Korsgren O. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups. J. Med. Sci. 2000, 105:125-133.
7. Bennet W., Sundberg B., Groth C.G., Brendel M.D., Brandhorst D., Brandhorst H., Bretzel R.G., Elgue G., Larsson R., Nilsson B., Korsgren O. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation?. Diabetes 1999, 48:1907-1914.
8. Berman D.M., Cabrera O., Kenyon N.M., Miller J., Tam S.H., Khandekar V.S., Picha K.M., Soderman A.R., Jordan R.E., Bugelski P.J., Horninger D., Lark M., Davis J.E., Alejandro R., Berggren P.O., Zimmerman M., O'Neil J.J., Ricordi C., Kenyon N.S. Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model. Transplantation 2007, 84:308-315.
9. Beuneu C., Vosters O., Ling Z., Pipeleers D., Pradier O., Goldman M., Verhasselt V. N-acetylcysteine derivative inhibits procoagulant activity of human islet cells. Diabetologia 2007, 50:343-347.
10. Cabric S., Eich T., Sanchez J., Nilsson B., Korsgren O., Larsson R. A new method for incorporating functional heparin onto the surface of islets of Langerhans. Tissue Eng., C: Methods 2008, 14:141-147.
11. Cabric S., Sanchez J., Johansson U., Larsson R., Nilsson B., Korsgren O., Magnusson P.U. Anchoring of vascular endothelial growth factor to surface-immobilized heparin on pancreatic islets: implications for stimulating islet angiogenesis. Tissue Eng., A 2010, 16:961-970.
12. Cabric S., Sanchez J., Lundgren T., Foss A., Felldin M., Kallen R., Salmela K., Tibell A., Tufveson G., Larsson R., Korsgren O., Nilsson B. Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes 2007, 56:2008-2015.
13. Chen H., Teramura Y., Iwata H. Co-immobilization of urokinase and thrombomodulin on islet surfaces by poly(ethylene glycol)-conjugated phospholipid. J. Controlled Release 2011, 150:229-234. (official journal of the Controlled Release Society).
14. Contreras J.L., Eckstein C., Smyth C.A., Bilbao G., Vilatoba M., Ringland S.E., Young C., Thompson J.A., Fernandez J.A., Griffin J.H., Eckhoff D.E. Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes 2004, 53:2804-2814.
15. Contreras J.L., Eckstein C., Smyth C.A., Sellers M.T., Vilatoba M., Bilbao G., Rahemtulla F.G., Young C.J., Thompson J.A., Chaudry I.H., Eckhoff D.E. Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes 2003, 52:2935-2942.
16. Cui W., Wilson J.T., Wen J., Angsana J., Qu Z., Haller C.A., Chaikof E.L. Thrombomodulin improves early outcomes after intraportal islet transplantation. Am. J. Transplant. 2009, 9:1308-1316. (official journal of the American Society of Transplantation and the American Society of Transplant Surgeons).
17. Del Conde I., Cruz M.A., Zhang H., Lopez J.A., Afshar-Kharghan V. Platelet activation leads to activation and propagation of the complement system. J. Exp. Med. 2005, 201:871-879.
18. Ghebrehiwet B., Silverberg M., Kaplan A.P. Activation of the classical pathway of complement by Hageman factor fragment. J. Exp. Med. 1981, 153:665-676.
19. Goto M., Groth C.G., Nilsson B., Korsgren O. Intraportal pig islet xenotransplantation into athymic mice as an in vivo model for the study of the instant blood-mediated inflammatory reaction. Xenotransplantation 2004, 11:195-202.
20. Goto M., Tjernberg J., Dufrane D., Elgue G., Brandhorst D., Ekdahl K.N., Brandhorst H., Wennberg L., Kurokawa Y., Satomi S., Lambris J.D., Gianello P., Korsgren O., Nilsson B. Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantation. Xenotransplantation 2008, 15:225-234.
21. Gulla K.C., Gupta K., Krarup A., Gal P., Schwaeble W.J., Sim R.B., O'Connor C.D., Hajela K. Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot. Immunology 2010, 129:482-495.
22. Gustavson S.M., Rajotte R.V., Hunkeler D., Lakey J.R., Edgerton D.S., Neal D.W., Snead W.L., Penaloza A.R., Cherrington A.D. Islet auto-transplantation into an omental or splenic site results in a normal beta cell but abnormal alpha cell response to mild non-insulin-induced hypoglycemia. Am. J. Transplant. 2005, 5:2368-2377. (official journal of the American Society of Transplantation and the American Society of Transplant Surgeons).
23. Hamad O.A., Ekdahl K.N., Nilsson P.H., Andersson J., Magotti P., Lambris J.D., Nilsson B. Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets. J. Thromb. Haemost. 2008, 6:1413-1421.
24. Ji M., Yi S., Smith-Hurst H., Phillips P., Wu J., Hawthorne W., O'Connell P. The importance of tissue factor expression by porcine NICC in triggering IBMIR in the xenograft setting. Transplantation 2011, 91:841-846.
25. Johansson H., Lukinius A., Berne C., Felldin M., Foss A., Kallen R., Salmela K., Tibell A., Tufveson G., Elgue G., Korsgren O., Nilsson B. Tissue factor released by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005, 54(6):1755-1762.
26. Johansson U., Olsson A., Gabrielsson S., Nilsson B., Korsgren O. Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation. Biochem. Biophys. Res. Commun. 2003, 308:474-479.
27. Kirchhof N., Shibata S., Wijkstrom M., Kulick D.M., Salerno C.T., Clemmings S.M., Heremans Y., Galili U., Sutherland D.E., Dalmasso A.P., Hering B.J. Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation 2004, 11:396-407.
28. Koh A., Senior P., Salam A., Kin T., Imes S., Dinyari P., Malcolm A., Toso C., Nilsson B., Korsgren O., Shapiro A.M. Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success. Transplantation 2010, 89:465-471.
29. Lamblin A., Tournoys A., Gmyr V., Jourdain M., Lefebvre J., Kerr-Conte J., Proye C., Pattou F. [Coagulation activation with intraportal islets of Langerhans transplantation in swine]. Ann. Chir. 2001, 126:743-750.
30. Luan N.M., Teramura Y., Iwata H. Immobilization of soluble complement receptor 1 on islets. Biomaterials 2011, 32:4539-4545.
31. Moberg L., Johansson H., Lukinius A., Berne C., Foss A., Kallen R., Ostraat O., Salmela K., Tibell A., Tufveson G., Elgue G., Nilsson Ekdahl K., Korsgren O., Nilsson B. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002, 360:2039-2045.
32. Moberg L., Johansson H., Lukinius A., Berne C., Foss A., Källen R., Østraat Ø., Salmela K., Tibell A., Tufveson G., Elgue G., Nilsson Ekdahl K., Korsgren O., Nilsson B. Production of tissue factor by pancreatic islet cells triggers thrombotic reactions detrimental in clinical islet transplantation. Lancet 2002, 360:2039-2045.
33. Moberg L., Korsgren O., Nilsson B. Neutrophil granulocytes are the predominant cell type infiltrating the islets in contact with ABO-compatible blood. Clin. Exp. Immunol. 2005, 142:125-131.
34. Moll G., Jitschin R., von Bahr L., Rasmusson-Duprez I., Sundberg B., Lonnies L., Elgue G., Nilsson-Ekdahl K., Mougiakakos D., Lambris J.D., Ringden O., Le Blanc K., Nilsson B. Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses. PLoS One 2011, 6:e21703.
35. Moll G., Rasmusson-Duprez I., von Bahr L., Connolly-Andersen A.M., Elgue G., Funke L., Hamad O.A., Lonnies H., Magnusson P.U., Sanchez J., Teramura Y., Nilsson-Ekdahl K., Ringden O., Korsgren O., Nilsson B., Le Blanc K. Are therapeutic human mesenchymal stromal cells compatible with human blood?. Stem Cells 2012, 30:1565-1574.
36. Naziruddin B., Iwahashi S., Kanak M.A., Takita M., Itoh T., Levy M.F. Evidence for instant blood-mediated inflammatory reaction in clinical autologous islet transplantation. Am. J. Transplant. 2014, 14:428-437. (official journal of the American Society of Transplantation and the American Society of Transplant Surgeons).
37. Nilsson B., Ekdahl K.N., Korsgren O. Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment. Curr. Opin. Organ Transplant. 2011, 16:620-626.
38. Nilsson B., Korsgren O., Lambris J.D., Ekdahl K.N. Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?. Trends Immunol. 2010, 31:32-38.
39. Nilsson P.H., Ekdahl K.N., Magnusson P.U., Qu H., Iwata H., Ricklin D., Hong J., Lambris J.D., Nilsson B., Teramura Y. Autoregulation of thromboinflammation on biomaterial surfaces by a multicomponent therapeutic coating. Biomaterials 2013, 34:985-994.
40. Osterud B., Bjorklid E. Tissue factor in blood cells and endothelial cells. Front. Biosci. (Elite Ed) 2012, 4:289-299.
41. Ozmen L., Ekdahl K.N., Elgue G., Larsson R., Korsgren O., Nilsson B. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 2002, 51:1779-1784.
42. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
43. Ritis K., Doumas M., Mastellos D., Micheli A., Giaglis S., Magotti P., Rafail S., Kartalis G., Sideras P., Lambris J.D. A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J. Immunol. 2006, 177:4794-4802.
44. Rood P.P., Bottino R., Balamurugan A.N., Smetanka C., Ayares D., Groth C.G., Murase N., Cooper D.K., Trucco M. Reduction of early graft loss after intraportal porcine islet transplantation in monkeys. Transplantation 2007, 83:202-210.
45. 2O). J. Immunol. 2013, 190:6457-6467.
46. Saito Y., Goto M., Maya K., Ogawa N., Fujimori K., Kurokawa Y., Satomi S. Brain death in combination with warm ischemic stress during isolation procedures induces the expression of crucial inflammatory mediators in the isolated islets. Cell Transplant. 2010, 19:775-782.
47. Sims P.J., Wiedmer T. The response of human platelets to activated components of the complement system. Immunol. Today 1991, 12:338-342.
48. Teramura Y., Iwata H. Surface modification of islets with PEG-lipid for improvement of graft survival in intraportal transplantation. Transplantation 2009, 88:624-630.
49. Teramura Y., Oommen O.P., Olerud J., Hilborn J., Nilsson B. Microencapsulation of cells, including islets, within stable ultra-thin membranes of maleimide-conjugated PEG-lipid with multifunctional crosslinkers. Biomaterials 2013, 34:2683-2693.
50. Titus T.T., Horton P.J., Badet L., Handa A., Chang L., Agarwal A., McShane P., Giangrande P., Gray D.W. Adverse outcome of human islet-allogeneic blood interaction. Transplantation 2003, 75:1317-1322.
51. Tjernberg J., Ekdahl K.N., Lambris J.D., Korsgren O., Nilsson B. Acute antibody-mediated complement activation mediates lysis of pancreatic islets cells and may cause tissue loss in clinical islet transplantation. Transplantation 2008, 85:1193-1199.
52. Tokodai K., Goto M., Inagaki A., Nakanishi W., Okada N., Okada H., Satomi S. C5a-inhibitory peptide combined with gabexate mesilate prevents the instant blood-mediated inflammatory reaction in a rat model of islet transplantation. Transplant. Proc. 2010, 42:2102-2103.